Evolutionary Genomics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Evolutionary Genomics Stock Forecast and Price Target
The average target price for Evolutionary Genomics's stock set by renowned analysts in recent months is $0.00, representing a potential downside of approximately 0 from its last closing price if met by 2025. This estimation is based on a high estimate of $0.00 and a low estimate of $0.00. If you're interested in FNAM stock, looking at its competitors might also be a good idea.
N/A
.jpg)
Evolutionary Genomics EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Evolutionary Genomics's EBITDA has decreased from $-2.47M to $-990.00k – a 59.92% drop! For the next year, analysts predict that EBITDA will reach $-1.67M – an increase of 68.65%. Over the next eight years, experts believe that Evolutionary Genomics's EBITDA will grow at a rate of 95.93%.
Evolutionary Genomics EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Evolutionary Genomics has seen a decline in its EBIT, from $-2.88M to $-2.01M – a 30.21% decrease. In the next year, analysts predict that EBIT will jump to $-2.59M – up 28.85% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 33.67%.
Site Navigation
.jpg)